Trial Profile
A phase I trial to evaluate VTP-38443 for acute coronary syndrome
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 19 Dec 2014
Price :
$35
*
At a glance
- Drugs VTP 38443 (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions
- 19 Dec 2014 According to the information on the company website, Vitae Pharmaceuticals is planning to start this trial in the first half of 2016.
- 18 Dec 2014 New trial record